Molecular support for field cancerization in the head and neck

Cancer

Volumn 82, Issue 7, 1998, Pages 1376-1380

  Lydiatt, William M ^a   Anderson, Peter E ^b   Bazzana, Tullia ^c   Casale, Michelle ^c   Hughes, Christopher J ^d   Huvos, Andrew G ^c   Lydiatt, Daniel D ^a   Schantz, Stimson P ^c  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d ST VINCENT'S CLINIC   (Australia)

Author keywords

9p21; Dysplasia; Head and neck carcinoma; Leukeplakia; Loss of heterozygosity; Premalignant

Indexed keywords

ARTICLE; CHROMOSOME 9P; CONTROLLED STUDY; DYSPLASIA; HEAD AND NECK CANCER; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; MOUTH MUCOSA; MULTIPLE CANCER; PRIORITY JOURNAL; SECOND CANCER;

EID: 0032055792     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980401)82:7<1376::AID-CNCR22>3.0.CO;2-2     Document Type: Article

References (14)

1. Slaughter DP, Southwick HW, Smejkal W. "Field cancerization" in oral stratified squamous epithelium. Cancer 1953;6: 963-8.
2. Ruddon RW. Cancer biology. 3rd edition. New York: Oxford University Press, 1995.
3. Renan MJ. How many mutations are required for tumorigenesis? Implications from human cancer data. Mol Carcinog 1993;7:139-46.
4. Sidransky D, Frost P, Von Eschenbach A, Oyasu R, Preisinger AC, Vogelstein B. Clonal origin of bladder cancer. N Engl J Med 1992;326:737-40.
5. Carey TE. Field cancerization: are multiple primary cancers monoclonal or polyclonal? Ann Med 1996;28:183-8.
6. Worsham MJ, Wolman SR, Carey TE, Zarbo RJ, Benniger MS, Van Dyke DL. Common clonal origin of synchronous primary head and neck squamous cell carcinomas: analysis by tumor karyotypes and fluorescence in situ hybridization. Hum Pathol 1995;26:251-61.
7. Bedi GC, Westra WH, Gabrielson E, Koch W, Sidrandsky D. Multiple head and neck tumors: evidence for a common clonal origin. Cancer Res 1996;56:2484-7.
8. Califano J, van der Riet P, Westra W, Nawroz H, Clayman G, Piantadosi S, et al. Genetic progression model for head and neck cancer: implications of field cancerization. Cancer Res 1996;56:2488-92.
9. van der Reit P, Nawroz H, Hruban RH, Corio R, Tokino K, Koch W, et al. Frequent loss of chromosome 9p21-22 early in head and neck cancer progression. Cancer Res 1994;54: 1156-8.
10. Roz L, Chu LW, Porter S, Scully C, Speight P, Read A, et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Res 1996;56:1228-31.
11. El-Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Res 1995;55:2656-9.
12. Mao L, Lee JS, Fan YH, Ro JY, Batsakis JG, Lippman S, et al. Frequent microsatellite alterations at chromosomes 9p21 and 3p14 in oral premalignant lesions and their value in cancer risk assessment. Nature Med 1996;2:682-5.
13. Lydiatt WM, Murty VVVS, Davidson BJ, Xu L, Dyomina K, Sacks PG, et al. Homozygous deletions and loss of expression of the CDKN2 gene occurs frequently in head and neck squamous cell carcinoma cell lines but infrequently in primary tumors. Genes Chromosom Cancer 1995;13:94-8.
14. Lydiatt WM, Davidson BJ, Shah J, Schantz SP, Chaganti RSK. The relationship of loss of heterozygosity to tobacco exposure and early recurrence in head and neck squamous cell carcinoma. Am J Surg 1994;168:437-40.